× Business
TelecomHealthcareDigital MarketingERPRetailMedia and EntertainmentOil and GasFood and BeveragesMarketing and AdvertisingBanking and InsuranceMetals and MiningLegalComplianceCryptocurrency
Technology
Big DataCloudIT ServiceSoftwareMobileSecurityNetworkingStorageCyber SecuritySAPData AnalysisloTBio TechQuality AssuranceEducationE-commerceGaming and VFXArtificial Intelligencescience-and-technology
Platform
Cisco DATABASE Google IBM Juniper Microsoft M2M Oracle Red hat Saas SYMANTEC
Leadership
CEO ReviewCMO ReviewCFO ReviewCompany Review
Magazines
US ASIA ARCHIVE
Startups Opinion Yearbook Readers Speak Contact Us

BIO TECH 

FEATURED

Cornell University researchers produce 3D printed prosthetic limbs

Prosthetics are a boon of medical science. They mitigate many of the everyday problems faced by individuals without limbs. Artificial limbs have been around in one form or the other for centuries. In ...  Read More

siliconreview-cornell-university-prosthetic-limbs

TRENDING


NEWS

siliconreview-scientists-look-upon-to-expunge-memories-that-provoke-anxiety

Scientists look upon to expunge memories that provoke anxiety

Findings of Columbia University Medical Center (CUMC) unveiled something unimaginable. And that jaw-dropping news is…. CUMC and McGill University suggest that there is a po...   Read More

siliconreview-bacteria-can-now-be-used-to-make-natural-colors-from-simple-sugar

Bacteria can now be used to make natural colors from simple sugar

Researchers at Rensselaer Polytechnic Institute have shown that four strains of E. coli bacteria working together can convert sugar into the natural red anthocyanin pigment found i...   Read More

siliconreview-pharma-mammoth-merck-sharp-dohme-msd-and-german-noxxon-pharma-begin-testing-immunoncologic-combo

Pharma mammoth Merck Sharp & Dohme (MSD) and German Noxxon Pharma begin testing immunoncologic combo

In the December of 2016, Berlin based Noxxon Pharma AG made a deal with Merck & Co. /MSD to assess the synergistic potential of NOXA1/2 and pembrolizumab immune cancer therapy....   Read More


YOU MIGHT ALSO LIKE::

ENROLL FOR UPCOMING ISSUE